Dichlorphenamide

FDA Drug Profile — Keveyis, Dichlorphenamide, ORMALVI

Dichlorphenamide is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand names including Keveyis, Dichlorphenamide, ORMALVI. Available dosage forms: powder, tablet.

Drug details

Generic Name
Dichlorphenamide
Brand Names
Keveyis, Dichlorphenamide, ORMALVI
Application Number
NDA011366
Sponsor
NURAY CHEMICALS PRIVATE LIMITED
NDC Codes
7
Dosage Forms
POWDER, TABLET
Routes
ORAL
Active Ingredients
DICHLORPHENAMIDE

Indications and Usage

1 INDICATIONS AND USAGE Dichlorphenamide tablets are indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants. Dichlorphenamide tablets are an oral carbonic anhydrase inhibitor indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.